Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Government May Move...

    Government May Move Supreme Court to Club all FDC Drugs Ban Cases

    Written by savita thakur thakur Published On 2016-05-01T10:22:24+05:30  |  Updated On 1 May 2016 10:22 AM IST
    Government May Move Supreme Court to Club all FDC Drugs Ban Cases

    New Delhi : Government today said it may move the Supreme Court asking it to club all cases related to its ban on 344 fixed dose combination drugs pending in various courts.


    Responding to a supplementary in the Lok Sabha on whether the Centre would move the apex court requesting it to club all cases opposing the ban together, Health Minister J P Nadda said it was a "good sugestion."

    Nadda also admitted that the situation was a result of lack of coordination between various state licencing authorities and the Drugs Controller General of India.

    The Delhi High Court alone was hearing 180 pleas challenging the government's decision to ban 344 fixed dose combinations.

    The Union Health Ministry in March had banned 344 fixed dose combination drugs, including cough syrup compositions, saying they involve "risk" to humans and safer alternatives were available.

    "On the basis of recommendations of the said expert committee, the central government is satisfied that it is necessary and expedient in public interest to regulate by way of prohibition of manufacture for sale, sale and distribution for human use of the said drugs in the country," the notification said.

    Fixed dose combination drugs are combinations of two or more active drugs in a single dose form.

    Nadda said some fixed drug combinations are necessary in treatment of malaria and diabetes.
    Delhi high courtdiabetesDrugs Controller General of IndiaFDCFixed Dose CombinationmalariaShri J P NaddaSupreme Court
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok